logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > White Crystalline Powder Articaine Hydrochloride CAS 23964-57-0

White Crystalline Powder Articaine Hydrochloride CAS 23964-57-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 23964-57-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: D/A,L/C,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:

White Crystalline Powder Articaine Hydrochloride

,

Articaine Hydrochloride CAS 23964-57-0

,

Articaine Hydrochloride

Appearance::
White Crystalline Powder
CAS NO::
23964-57-0
Molecular Formula::
C13H21ClN2O3S
Molecular Weight::
320.83500
EINECS NO::
245-957-7
MDL NO::
MFCD00190157
Appearance::
White Crystalline Powder
CAS NO::
23964-57-0
Molecular Formula::
C13H21ClN2O3S
Molecular Weight::
320.83500
EINECS NO::
245-957-7
MDL NO::
MFCD00190157
White Crystalline Powder Articaine Hydrochloride CAS 23964-57-0

Product Description:

Product Name: Articaine hydrochloride CAS NO: 23964-57-0


Synonyms:

methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate,hydrochloride;

Articaine HCl;

methyl 4-methyl-3-(2-(propylamino)propanamido)thiophene-2-carboxylate hydrochloride;


Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.00%

Density: 1.178 g/cm3

Boiling Point: 440.6℃ at 760 mmHg

Flash Point: 220.3℃

Vapor Pressure: 5.79E-08mmHg at 25℃


Safety Information:

HS Code: 2934999090

Hazard Code: Xi

Risk Statements: R36/37/38

Safety Statement: S26

WGK Germany: 3


Articaine Hydrochloride is a dental local anesthetic.Target: OthersArticaine Hydrochloride is a dental local anesthetic. Articaine: VAS (Visual Analogue Scale) scores (from 0 to 10 cm) by patients 4 to < 13 years of age are 0.5 for simple procedures and 1.1 for complex procedures, and average investigator scores are 0.4 and 0.6 for simple and complex procedures, respectively. No serious adverse events related to the articaine occurres, the only adverse event considered related to articaine is accidental lip injury in one patient. Articaine results in success rate of 64.5% in electronic pulp testing in healthy adult volunteers injected with 4% articaine. Articaine infiltration produces significantly more episodes of no response to maximum stimulation in first molars than l-idocaine. Mandibular buccal infiltration is more effective with 4% articaine with epinephrine compared to 2% l-idocaine with epinephrine. Articaine formulation results in successful pulpal anesthesia ranged from 75 to 92 percent and onset of pulpal anesthesia ranged from 4.2 to 4.7 minutes in healthy volunteer. For articaine, 4 percent (two of 56) of the subjects reported swelling and no subjects reported bruising. Ninety-eight percent (59 of 60) of the subjects had lip numbness with the articaine solution.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.